Ken's Honeydew is a modern hybrid strain developed from a genetic cross between an undisclosed indica and Ken's Kush. The history and specific breeding origin of this strain remain undocumented, leaving its precise development timeline and creator unknown. As a modern hybrid, it is managed through a moderate cultivation difficulty and thrives in both indoor and outdoor environments. Growers can expect a high yield from this variety, provided the plants are allowed to complete their 74-day flowering cycle.

The aromatic and flavor profile of Ken's Honeydew is complex, characterized by a diverse arrangement of thirteen identified terpenes. The profile is confirmed to be dominated by caryophyllene, followed by myrcene, limonene, and pinene. Further depth is provided by linalool, humulene, beta-pinene, and ocimene, with trace contributions from nerolidol, guaiol, p-cymene, bisabolol, and terpinolene. This specific chemical composition gives the strain its unique sensory characteristics, though individual experiences with these volatile compounds may vary based on cultivation conditions.

As a THC-dominant cultivar, Ken's Honeydew is formulated to produce effects that are relaxed, happy, and uplifted. These therapeutic properties make it a candidate for users seeking relief from stress and pain, or support for sleep regulation. While it possesses distinct pharmacological goals, no notable offspring have been recorded to date, meaning its current influence on future breeding projects remains limited.